# EDGAR Filing Document

**Accession Number:** 0001090872
**File Stem:** 0000950170-23-000508
**Filing Date:** 2023-1
**Character Count:** 9570
**Document Hash:** cdc380f809a37f0ae9aa4e51bd53e079
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-000508.hdr.sgml**: 20230109

**ACCESSION NUMBER**: 0000950170-23-000508

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230109

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230109

**DATE AS OF CHANGE**: 20230109

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AGILENT TECHNOLOGIES, INC.
- **CENTRAL INDEX KEY:** 0001090872
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **IRS NUMBER:** 770518772
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15405
- **FILM NUMBER:** 23518260

**BUSINESS ADDRESS:**
- **STREET 1:** 5301 STEVENS CREEK BLVD
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95051
- **BUSINESS PHONE:** (408) 345-8886

**MAIL ADDRESS:**
- **STREET 1:** 5301 STEVENS CREEK BLVD, MS 1A-LC
- **STREET 2:** P.O. BOX 58059
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95052-8059

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AGILENT TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19990816

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HP MEASUREMENT INC
- **DATE OF NAME CHANGE:** 19990716

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

**FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** January 09, 2023<br>

------

AGILENT TECHNOLOGIES, INC.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-15405 | 77-0518772 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 5301 Stevens Creek Boulevard |  |  |
| Santa Clara**,** California |  | 95051 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 800 227-9770<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| **<br>Title of each class** | **<br>Name of each exchange on which registered** |
| Common Stock, $0.01 par value<br> A | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 8.01 Other**

On January 9, 2023, Agilent Technologies, Inc. (the "Company") issued a press release announcing that the Board of Directors of the Company approved a stock repurchase program authorizing the purchase of up to $2 billion of the Company's common stock (the "2023 Stock Repurchase Program"). The 2023 Stock Repurchase Program will commence on March 1, 2023.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

Exhibit 99.1 is furnished as an exhibit to this report and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Exhibit No.** | &nbsp;&nbsp;**Description** |
| &nbsp;&nbsp;99.1 | &nbsp;&nbsp;[<u>Press release dated January 9, 2023 regarding stock repurchase program</u>](a-ex99_1.htm) |
| &nbsp;&nbsp;104 | &nbsp;&nbsp;Cover page interactive data file (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **AGILENT TECHNOLOGIES, INC.** |
| Date: | January 9, 2023 | By:  | /s/ P. Diana Chiu |
|  |  | Name:  | P. Diana Chiu |
|  |  | Title: | Vice President, Assistant General Counsel<br>& Assistant Secretary |

---

------

## Exhibit 99.1

![img81546852_0.jpg](img81546852_0.jpg)

**Exhibit 99.1**

**Agilent Authorizes $2 Billion Share Repurchase Program**

**SANTA CLARA, California, January 9, 2023** – Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company's common stock.

"Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders," said Bob McMahon, Agilent chief financial officer. "This share repurchase program is a key element of that strategy."

The new program will begin March 1. Upon commencement, the new repurchase program replaces Agilent's existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.

The number of shares to be repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements. The stock repurchase program may be suspended or discontinued at any time.

**About Agilent Technologies**

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at <u>www.agilent.com</u>. To receive the latest Agilent news, subscribe to the <u>Agilent Newsroom</u>. Follow Agilent on <u>LinkedIn</u> and <u>Facebook</u>.

**Forward Looking Statements**

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking

------

statements contained herein include, but are not limited to, statements regarding the company's share repurchase programs. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent's customers' businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; the adverse impacts of and risks posed by the COVID-19 pandemic; and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the fiscal quarter ended October 31, 2022. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

# # # # #

**Media Contact: Investor Contact:**

Sarah Litton Parmeet Ahuja

+1 669 255 7696 +1 408-345-8948

sarah.litton@agilent.com parmeet_ahuja@agilent.com

------